Skip to content

EAS-MED: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

EAS-MED

BE 0738.882.454
NACE 86.220, Specialist medical practice
financial year 2025 against 2026filed annual accounts (NBB)
Net result for the year
€50,993
2025 · €8,580+€42,414
Equity
€60,100
2025 · €9,107+€50,993
Cash
€5,224
2025 · €40+€5,184
Balance sheet total
€109,726
2025 · €72,918+€36,808

Largest movements

2025 to 2026
Assets
  • Receivables within one year +€24,141

    new in 2026: €24,141

    of which Other amounts receivable: +€23,000

  • Tangible fixed assets +€10,746

    up €10,746 (+16.9%), from €63,706 to €74,452

    of which Furniture and vehicles: +€21,530

  • Cash +€5,184

    up €5,184 (+12994.8%), from €40 to €5,224

    mainly Net result for the year (+€50,993) and Depreciation (+€13,020)

  • Deferred charges and accrued income -€3,263

    down €3,263 (-35.6%), from €9,173 to €5,910

Equity and liabilities
  • Profit (loss) carried forward +€50,993

    up €50,993 (+559.9%), from €9,107 to €60,100

  • Other debts -€16,744

    down €16,744 (-36.1%), from €46,369 to €29,626

  • Tax, wage and social debts +€10,345

    up €10,345 (+107.2%), from €9,655 to €20,000

  • Accrued charges and deferred income -€7,000

    no longer reported in 2026 (was €7,000)

Income statement
  • Gross operating margin +€67,971

    up €67,971 (+379.6%), from €17,906 to €85,877

  • Taxes +€27,393

    up €27,393, from -€7,508 to €19,885

  • Financial charges -€1,141

    down €1,141 (-44.9%), from €2,543 to €1,402

From the 2025 result to the 2026 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2025 €8,580
Gross operating margin +€67,971
Depreciation -€162
Other operating charges +€856
Financial income +€0
Financial charges +€1,141
Taxes -€27,393
Result 2026 €50,993

Cash bridge derived

cash 2025 to 2026

Derived from the 2025 and 2026 balance sheets and the 2026 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€28,950
Investment -€23,766
Financing €0
Cash 2025 €40
Net result for the year +€50,993
Depreciation +€13,020
Receivables within one year -€24,141
Deferred charges and accrued income +€3,263
Trade debts -€787
Tax, wage and social debts +€10,345
Other debts -€16,744
Accrued charges and deferred income -€7,000
Investment in fixed assets (net) -€23,766
Cash 2026 €5,224
Every line side by side 35 lines
Line Code 2025 2026 Change %
Total assets 20/58 €72,918 €109,726 +€36,808 +50.5%
Fixed assets 21/28 €63,706 €74,452 +€10,746 +16.9%
Tangible fixed assets 22/27 €63,706 €74,452 +€10,746 +16.9%
Land and buildings 22 €61,663 €51,087 -€10,576 -17.2%
Plant, machinery and equipment 23 €1,144 €937 -€208 -18.2%
Furniture and vehicles 24 €899 €22,429 +€21,530 +2395.8%
Current assets 29/58 €9,213 €35,274 +€26,061 +282.9%
Amounts receivable within one year 40/41 - €24,141 +€24,141
Trade receivables 40 - €1,141 +€1,141
Other amounts receivable 41 - €23,000 +€23,000
Cash at bank and in hand 54/58 €40 €5,224 +€5,184 +12994.8%
Deferred charges and accrued income 490/1 €9,173 €5,910 -€3,263 -35.6%
Total equity and liabilities 10/49 €72,918 €109,726 +€36,808 +50.5%
Equity 10/15 €9,107 €60,100 +€50,993 +559.9%
Profit (loss) carried forward 14 €9,107 €60,100 +€50,993 +559.9%
Amounts payable 17/49 €63,811 €49,626 -€14,186 -22.2%
Amounts payable within one year 42/48 €56,811 €49,626 -€7,186 -12.6%
Trade debts 44 €787 - -€787
Suppliers 440/4 €787 - -€787
Taxes, remuneration and social security 45 €9,655 €20,000 +€10,345 +107.2%
Taxes 450/3 €9,655 €20,000 +€10,345 +107.2%
Other amounts payable 47/48 €46,369 €29,626 -€16,744 -36.1%
Accrued charges and deferred income 492/3 €7,000 - -€7,000
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €12,858 €13,020 +€162 +1.3%
Other operating charges 640/8 €1,433 €578 -€856 -59.7%
Gross operating margin 9900 €17,906 €85,877 +€67,971 +379.6%
Operating profit (loss) 9901 €3,614 €72,280 +€68,665 +1899.8%
Financial income 75/76B - €0 +€0
Recurring financial income 75 - €0 +€0
Financial charges 65/66B €2,543 €1,402 -€1,141 -44.9%
Recurring financial charges 65 €2,543 €1,402 -€1,141 -44.9%
Profit (loss) for the period before taxes 9903 €1,071 €70,878 +€69,807 +6515.5%
Income taxes 67/77 -€7,508 €19,885 +€27,393
Profit (loss) for the period 9904 €8,580 €50,993 +€42,414 +494.4%
Profit (loss) for the period to be appropriated 9905 €8,580 €50,993 +€42,414 +494.4%

Source: filed annual accounts (NBB), financial years ended 31 March 2025 and 31 March 2026. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.